NASDAQ:FENC Adherex Technologies (FENC) Stock Price, News & Analysis $9.00 -0.18 (-1.96%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$9.00 0.00 (0.00%) As of 09/5/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Adherex Technologies Stock (NASDAQ:FENC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Adherex Technologies alerts:Sign Up Key Stats Today's Range$8.95▼$9.2950-Day Range$7.84▼$9.2452-Week Range$3.96▼$9.42Volume54,916 shsAverage Volume64,516 shsMarket Capitalization$251.19 millionP/E RatioN/ADividend YieldN/APrice Target$13.33Consensus RatingBuy Company Overview Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina. Read More Adherex Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreFENC MarketRank™: Adherex Technologies scored higher than 38% of companies evaluated by MarketBeat, and ranked 748th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingBuy Consensus RatingAdherex Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialAdherex Technologies has a consensus price target of $13.33, representing about 48.1% upside from its current price of $9.00.Amount of Analyst CoverageAdherex Technologies has only been the subject of 3 research reports in the past 90 days.Read more about Adherex Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Adherex Technologies are expected to decrease in the coming year, from ($0.11) to ($0.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Adherex Technologies is -21.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Adherex Technologies is -21.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Adherex Technologies' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.51% of the float of Adherex Technologies has been sold short.Short Interest Ratio / Days to CoverAdherex Technologies has a short interest ratio ("days to cover") of 17.6, which indicates bearish sentiment.Change versus previous month Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAdherex Technologies does not currently pay a dividend.Dividend GrowthAdherex Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.51% of the float of Adherex Technologies has been sold short.Short Interest Ratio / Days to CoverAdherex Technologies has a short interest ratio ("days to cover") of 17.6, which indicates bearish sentiment.Change versus previous month News and Social Media1.7 / 5News SentimentN/A News SentimentAdherex Technologies has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Adherex Technologies this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Adherex Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Adherex Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $176,746.00 in company stock.Percentage Held by Insiders11.76% of the stock of Adherex Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.51% of the stock of Adherex Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Adherex Technologies' insider trading history. Receive FENC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adherex Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FENC Stock News HeadlinesInsider Selling: Adherex Technologies Inc. (NASDAQ:FENC) Director Sells 10,000 Shares of StockAugust 6, 2025 | insidertrades.comAdherex Technologies (NASDAQ:FENC) Cut to "Hold" at Wall Street ZenAugust 30, 2025 | americanbankingnews.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.September 6 at 2:00 AM | Porter & Company (Ad)Fennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call TranscriptAugust 19, 2025 | seekingalpha.comFennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business UpdateAugust 14, 2025 | globenewswire.comFennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025August 11, 2025 | globenewswire.comRecent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's WhyJuly 15, 2025 | msn.comInsider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC)June 6, 2025 | gurufocus.comSee More Headlines FENC Stock Analysis - Frequently Asked Questions How have FENC shares performed this year? Adherex Technologies' stock was trading at $6.32 at the start of the year. Since then, FENC stock has increased by 42.4% and is now trading at $9.00. How were Adherex Technologies' earnings last quarter? Adherex Technologies Inc. (NASDAQ:FENC) announced its quarterly earnings data on Thursday, August, 14th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.05. The company earned $9.76 million during the quarter, compared to analyst estimates of $9.52 million. Read the conference call transcript. How do I buy shares of Adherex Technologies? Shares of FENC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Adherex Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Adherex Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Alphabet (GOOG). Company Calendar Last Earnings8/14/2025Today9/06/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:FENC CIK1211583 Webwww.fennecpharma.com Phone919-636-4530Fax919-890-0490Employees10Year FoundedN/APrice Target and Rating Average Price Target for Adherex Technologies$13.33 High Price Target$14.00 Low Price Target$13.00 Potential Upside/Downside+48.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$440 thousand Net Margins-35.05% Pretax Margin-35.05% Return on EquityN/A Return on Assets-23.92% Debt Debt-to-Equity RatioN/A Current Ratio4.85 Quick Ratio4.59 Sales & Book Value Annual Sales$47.54 million Price / Sales5.28 Cash Flow$0.03 per share Price / Cash Flow278.67 Book Value($0.21) per share Price / Book-42.86Miscellaneous Outstanding Shares27,910,000Free Float24,629,000Market Cap$251.19 million OptionableOptionable Beta0.58 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:FENC) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
